Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer

Journal of Urology

Volumn 171, Issue 1, 2004, Pages 177-181

  Augustin, Herbert ^a,b   Eggert, Thilo ^a   Wenske, Sven ^a   Karakiewicz, Pierre I ^c   Palisaar, Jüri ^a   Daghofer, Fedor ^b   Huland, Hartwig ^a   Graefen, Markus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Predictive value of tests; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PARTIN TABLE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE;

EID: 0348109409     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000099827.77355.a7     Document Type: Article

References (20)

1. Ross, P. L., Scardino, P. T. and Kattan, M. W.: A catalog of prostate cancer nomograms. J Urol, 165: 1562, 2001
2. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. et al: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol, 150: 110, 1993
3. Kattan, M. W., Stapleton, A. M., Wheeler, T. M. and Scardino, P. T.: Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer, 79: 528, 1997
4. Partin, A. W., Kattan, M. W., Subong, E. N., Walsh, P. C., Wojno, K. J., Oesterling, J. E. et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 277: 1445, 1997
5. Blute, M. L., Bergstralh, E. J., Partin, A. W., Walsh, P. C., Kattan, M. W., Scardino, P. T. et al: Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol, 164: 1591, 2000
6. Graefen, M., Augustin, H., Karakiewicz, P. I., Hammerer, P. G., Haese, A., Palisaar, J. et al: Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Eur Urol, 43: 6, 2003
7. Partin, A. W., Mangold, L. A., Lamm, D. M., Walsh, P. C., Epstein, J. I. and Pearson, J. D.: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology, 58: 843, 2001
8. Conrad, S., Graefen, M., Pichlmeier, U., Henke, R.-P., Erbersdobler, A., Hammerer, P. G. et al: Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma. J Urol, 167: 521, 2002
9. Beahrs, O. H., Henson, D. E., Hutter, R. V. P. and Kennedy, B. J.: Manual for Staging of Cancer: AJCC Cancer Staging Manual, 4th ed. Philadelphia: J. B. Lippincott, pp. 181-186, 1992
10. Gleason, D. F.: Histologic grading and clinical staging of prostate carcinoma. In: Urologic Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea and Febiger, pp. 171-197, 1977
11. McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol, 12: 897, 1988
12. Noldus, J., Graefen, M., Haese, A., Henke, R. P., Hammerer, P. and Huland, H.: Stage migration in clinically localized prostate cancer. Eur Urol, 38: 74, 2000
13. Han, M., Partin, A. W., Piantadosi, S., Epstein, J. I. and Walsh, P. C.: Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol, 166: 416, 2001
14. Makarov, D. V., Sanderson, H., Partin, A. W. and Epstein, J. I.: Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores? J Urol, 167: 2440, 2002
15. Kattan, M. W., Eastham, J. A., Stapleton, A. M., Wheeler, T. M. and Scardino, P. T.: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst, 90: 766, 1998
16. Chan, T. Y., Partin, A. W., Walsh, P. C. and Epstein, J. I.: Prognostic significance of Gleason score 3 + 4 versus Gleason score 4 + 3 tumor at radical prostatectomy. Urology, 56: 823, 2000
17. Herman, C. M., Kattan, M. W., Ohori, M., Scardino, P. T. and Wheeler, T. M.: Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy. Am J Surg Pathol, 25: 657, 2001
18. Cookson, M. S., Fleshner, N. E., Soloway, S. M. and Fair, W. R.: Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol, 157: 559, 1997
19. Penson, D. F., Grossfeld, G. D., Li, Y.-P., Henning, J. M., Lubeck, D. P. and Carroll, P. R.: How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the Cancer of the Prostate Strategic Urological Research Endeavor. J Urol, 167: 1653, 2002
20. Zlotta, A. R., Remzi, M., Snow, P. B., Schulman, C. C., Marberger, M. and Djavan, B.: An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less. J Urol, 169: 1724, 2003